MedTrace Logo

Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users

NCT05922735 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2023-06-28

No results posted yet for this study

Summary

This is a cohort, non-health product, non-interventional biomedical research, multi-centric, to determine the seroprevalence of mpox infection in the population of people living with HIV and in PrEP users in Ile-de-France and in the province.

Conditions

  • Monkey Pox
  • HIV Infections

Interventions

BEHAVIORAL

Questionnaire

Serology from remaining blood sample Self-questionnaire about sexual behavior during the epidemy mpox

Sponsors & Collaborators

  • INSERM UMR S 1136

    collaborator OTHER

  • Institut de Recherche en Santé Publique, France

    collaborator OTHER

  • Institut Pasteur

    collaborator INDUSTRY

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Valérie POURCHER, Pr · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2025-02-01
Completion
2025-02-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05922735 on ClinicalTrials.gov